List of Tables
Table 1. Global Anti-Parkinson's Disease Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-Parkinson's Disease Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-Parkinson's Disease Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-Parkinson's Disease Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-Parkinson's Disease Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-Parkinson's Disease Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-Parkinson's Disease Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-Parkinson's Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-Parkinson's Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Parkinson's Disease Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Parkinson's Disease Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Parkinson's Disease Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Parkinson's Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Parkinson's Disease Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Parkinson's Disease Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-Parkinson's Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-Parkinson's Disease Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Anti-Parkinson's Disease Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-Parkinson's Disease Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Parkinson's Disease Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-Parkinson's Disease Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-Parkinson's Disease Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-Parkinson's Disease Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-Parkinson's Disease Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-Parkinson's Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-Parkinson's Disease Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-Parkinson's Disease Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-Parkinson's Disease Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-Parkinson's Disease Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-Parkinson's Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-Parkinson's Disease Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-Parkinson's Disease Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-Parkinson's Disease Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-Parkinson's Disease Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-Parkinson's Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-Parkinson's Disease Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-Parkinson's Disease Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Parkinson's Disease Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-Parkinson's Disease Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-Parkinson's Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-Parkinson's Disease Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-Parkinson's Disease Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Parkinson's Disease Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Anti-Parkinson's Disease Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Anti-Parkinson's Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Anti-Parkinson's Disease Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Anti-Parkinson's Disease Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Anti-Parkinson's Disease Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-Parkinson's Disease Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-Parkinson's Disease Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-Parkinson's Disease Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Anti-Parkinson's Disease Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Anti-Parkinson's Disease Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-Parkinson's Disease Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-Parkinson's Disease Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-Parkinson's Disease Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-Parkinson's Disease Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-Parkinson's Disease Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-Parkinson's Disease Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-Parkinson's Disease Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-Parkinson's Disease Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Anti-Parkinson's Disease Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Anti-Parkinson's Disease Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-Parkinson's Disease Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-Parkinson's Disease Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-Parkinson's Disease Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-Parkinson's Disease Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-Parkinson's Disease Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
Table 71. Guangzhou Kanghe Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Guangzhou Kanghe Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Guangzhou Kanghe Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 74. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Tianjin Lisheng Pharmaceutical Co., Ltd. Company Information
Table 76. Tianjin Lisheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Tianjin Lisheng Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Tianjin Lisheng Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 79. Tianjin Lisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Changzhou Kangpu Pharmaceutical Co., Ltd. Company Information
Table 81. Changzhou Kangpu Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Changzhou Kangpu Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Changzhou Kangpu Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 84. Changzhou Kangpu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Company Information
Table 86. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 89. Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Company Information
Table 91. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 94. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Hunan Zhongnan Pharmaceutical Co., Ltd. Company Information
Table 96. Hunan Zhongnan Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Hunan Zhongnan Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hunan Zhongnan Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 99. Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
Table 101. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 104. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Ningbo Dahongying Pharmaceutical Co., Ltd. Company Information
Table 106. Ningbo Dahongying Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Ningbo Dahongying Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Ningbo Dahongying Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 109. Ningbo Dahongying Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
Table 111. Beijing Fuyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Beijing Fuyuan Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Beijing Fuyuan Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 114. Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
Table 116. Zhejiang Huahai Pharmaceutical Co., Ltd. Description and Business Overview
Table 117. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 119. Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Hangzhou Guoguang Pharmaceutical Co., Ltd. Company Information
Table 121. Hangzhou Guoguang Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Hangzhou Guoguang Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hangzhou Guoguang Pharmaceutical Co., Ltd. Anti-Parkinson's Disease Drugs Product
Table 124. Hangzhou Guoguang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Merck Company Information
Table 126. Merck Description and Business Overview
Table 127. Merck Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Merck Anti-Parkinson's Disease Drugs Product
Table 129. Merck Recent Developments/Updates
Table 130. Akorn Company Information
Table 131. Akorn Description and Business Overview
Table 132. Akorn Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Akorn Anti-Parkinson's Disease Drugs Product
Table 134. Akorn Recent Developments/Updates
Table 135. GSK Company Information
Table 136. GSK Description and Business Overview
Table 137. GSK Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. GSK Anti-Parkinson's Disease Drugs Product
Table 139. GSK Recent Developments/Updates
Table 140. Novartis Company Information
Table 141. Novartis Description and Business Overview
Table 142. Novartis Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Novartis Anti-Parkinson's Disease Drugs Product
Table 144. Novartis Recent Developments/Updates
Table 145. Boehringer Ingelheim Company Information
Table 146. Boehringer Ingelheim Description and Business Overview
Table 147. Boehringer Ingelheim Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Boehringer Ingelheim Anti-Parkinson's Disease Drugs Product
Table 149. Boehringer Ingelheim Recent Developments/Updates
Table 150. Teva Pharmaceutical Company Information
Table 151. Teva Pharmaceutical Description and Business Overview
Table 152. Teva Pharmaceutical Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Teva Pharmaceutical Anti-Parkinson's Disease Drugs Product
Table 154. Teva Pharmaceutical Recent Developments/Updates
Table 155. Abbvie Company Information
Table 156. Abbvie Description and Business Overview
Table 157. Abbvie Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Abbvie Anti-Parkinson's Disease Drugs Product
Table 159. Abbvie Recent Developments/Updates
Table 160. Kyowa Kirin Company Information
Table 161. Kyowa Kirin Description and Business Overview
Table 162. Kyowa Kirin Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Kyowa Kirin Anti-Parkinson's Disease Drugs Product
Table 164. Kyowa Kirin Recent Developments/Updates
Table 165. Astellas Pharma Company Information
Table 166. Astellas Pharma Description and Business Overview
Table 167. Astellas Pharma Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Astellas Pharma Anti-Parkinson's Disease Drugs Product
Table 169. Astellas Pharma Recent Developments/Updates
Table 170. Desitin Arzneimittel Company Information
Table 171. Desitin Arzneimittel Description and Business Overview
Table 172. Desitin Arzneimittel Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Desitin Arzneimittel Anti-Parkinson's Disease Drugs Product
Table 174. Desitin Arzneimittel Recent Developments/Updates
Table 175. Endo International plc Company Information
Table 176. Endo International plc Description and Business Overview
Table 177. Endo International plc Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Endo International plc Anti-Parkinson's Disease Drugs Product
Table 179. Endo International plc Recent Developments/Updates
Table 180. Roche Holding AG Company Information
Table 181. Roche Holding AG Description and Business Overview
Table 182. Roche Holding AG Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Roche Holding AG Anti-Parkinson's Disease Drugs Product
Table 184. Roche Holding AG Recent Developments/Updates
Table 185. Lundbeck Company Information
Table 186. Lundbeck Description and Business Overview
Table 187. Lundbeck Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Lundbeck Anti-Parkinson's Disease Drugs Product
Table 189. Lundbeck Recent Developments/Updates
Table 190. Valeant Company Information
Table 191. Valeant Description and Business Overview
Table 192. Valeant Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 193. Valeant Anti-Parkinson's Disease Drugs Product
Table 194. Valeant Recent Developments/Updates
Table 195. Apokyn Company Information
Table 196. Apokyn Description and Business Overview
Table 197. Apokyn Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 198. Apokyn Anti-Parkinson's Disease Drugs Product
Table 199. Apokyn Recent Developments/Updates
Table 200. Orion Company Information
Table 201. Orion Description and Business Overview
Table 202. Orion Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 203. Orion Anti-Parkinson's Disease Drugs Product
Table 204. Orion Recent Developments/Updates
Table 205. Stada Arzneimittel Company Information
Table 206. Stada Arzneimittel Description and Business Overview
Table 207. Stada Arzneimittel Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 208. Stada Arzneimittel Anti-Parkinson's Disease Drugs Product
Table 209. Stada Arzneimittel Recent Developments/Updates
Table 210. Bausch Health Company Information
Table 211. Bausch Health Description and Business Overview
Table 212. Bausch Health Anti-Parkinson's Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 213. Bausch Health Anti-Parkinson's Disease Drugs Product
Table 214. Bausch Health Recent Developments/Updates
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Anti-Parkinson's Disease Drugs Distributors List
Table 218. Anti-Parkinson's Disease Drugs Customers List
Table 219. Anti-Parkinson's Disease Drugs Market Trends
Table 220. Anti-Parkinson's Disease Drugs Market Drivers
Table 221. Anti-Parkinson's Disease Drugs Market Challenges
Table 222. Anti-Parkinson's Disease Drugs Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
Table 226. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-Parkinson's Disease Drugs
Figure 2. Global Anti-Parkinson's Disease Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-Parkinson's Disease Drugs Market Share by Type: 2023 & 2030
Figure 4. Anticholinergics Product Picture
Figure 5. Dopaminergics Product Picture
Figure 6. Global Anti-Parkinson's Disease Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Anti-Parkinson's Disease Drugs Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global Anti-Parkinson's Disease Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Anti-Parkinson's Disease Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Anti-Parkinson's Disease Drugs Sales (2019-2030) & (K Units)
Figure 15. Global Anti-Parkinson's Disease Drugs Average Price (US$/Unit) & (2019-2030)
Figure 16. Anti-Parkinson's Disease Drugs Report Years Considered
Figure 17. Anti-Parkinson's Disease Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Anti-Parkinson's Disease Drugs Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Anti-Parkinson's Disease Drugs Players: Market Share by Revenue in Anti-Parkinson's Disease Drugs in 2023
Figure 20. Anti-Parkinson's Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Anti-Parkinson's Disease Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Anti-Parkinson's Disease Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Anti-Parkinson's Disease Drugs Revenue Market Share by Country (2019-2030)
Figure 24. United States Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Anti-Parkinson's Disease Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Anti-Parkinson's Disease Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Anti-Parkinson's Disease Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Anti-Parkinson's Disease Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Anti-Parkinson's Disease Drugs Sales Market Share by Country (2019-2030)
Figure 43. Mexico Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Anti-Parkinson's Disease Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Anti-Parkinson's Disease Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Anti-Parkinson's Disease Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Anti-Parkinson's Disease Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of Anti-Parkinson's Disease Drugs by Type (2019-2030)
Figure 54. Global Anti-Parkinson's Disease Drugs Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Anti-Parkinson's Disease Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of Anti-Parkinson's Disease Drugs by Application (2019-2030)
Figure 57. Global Anti-Parkinson's Disease Drugs Price (US$/Unit) by Application (2019-2030)
Figure 58. Anti-Parkinson's Disease Drugs Value Chain
Figure 59. Anti-Parkinson's Disease Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
